Literature DB >> 22057548

A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma.

S Ermakov1, S Trofimov, I Malkin, G Livshits.   

Abstract

SUMMARY: There is a paucity of studies investigating association between ROR2 gene variants and osteoporosis and osteoarthritis-related phenotypes. The published literature suggests that osteoprotegerin (OPG) and receptor activator of nuclear factor-kB ligand (RANKL) are essential for bone metabolism and correlate with osteoarthritis manifestation and progression. The present study provides evidence of the significant association between ROR2 variants and the OPG/RANKL ratio in human plasma. The present results also suggest significant association between ROR2 polymorphisms and severity of radiographic hand osteoarthritis.
INTRODUCTION: Despite the importance of the ROR-2 in skeletal physiology, there is a paucity of studies investigating the potential association of ROR2 gene variants with phenotypes relevant to osteoporosis and osteoarthritis. On the other hand, there is a considerable body of literature suggesting that OPG and RANKL and their ratio (OPG/RANKL) are essential for regulating bone resorption. This is also correlated with osteoarthritis manifestation and progression. The present study therefore examines whether ROR2 polymorphisms may be associated with the OPG/RANKL ratio and hand osteoarthritis (HOA).
METHODS: The study was conducted in a family-based sample of 1,515 Caucasian individuals, assessed for radiographic hand osteoarthritis, using the Kellgren/Lawrence score. Of these, 865 individuals were genotyped for 19 SNPs, relatively equally covering the ROR2 locus, and their plasma levels of OPG and RANKL were assayed. The association between the selected SNPs and OPG, along with the OPG/RANKL ratio and HOA, was explored using the pedigree disequilibrium test.
RESULTS: Of the total of 57 tests, 16 nominally significant results (p < 0.05) were obtained, which is considerably more than the three normally expected for type I error. The significant association signals for all three phenotypes were mapped to the intron 1 region. The most significant results were detected between OPG/RANKL and rs7048756 (p < 0.0005) and between adjacent rs4744107 and Kellgren/Lawrence score (p = 0.006).
CONCLUSIONS: The present study provides evidence of the significant association between ROR2 variants and the OPG/RANKL ratio in human plasma and also suggests ROR2 association with HOA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22057548     DOI: 10.1007/s00198-011-1820-x

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  48 in total

1.  Familial factors of blood pressure and adiposity covariation.

Authors:  G Livshits; L M Gerber
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

Review 2.  Wnt signaling in bone metabolism.

Authors:  Takuo Kubota; Toshimi Michigami; Keiichi Ozono
Journal:  J Bone Miner Metab       Date:  2009-03-31       Impact factor: 2.626

3.  Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification process.

Authors:  Hiroshi Kawaguchi
Journal:  J Bone Miner Res       Date:  2009-01       Impact factor: 6.741

Review 4.  Matrix metalloproteinases and bone.

Authors:  Stephen M Krane; Masaki Inada
Journal:  Bone       Date:  2008-04-04       Impact factor: 4.398

5.  Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.

Authors:  M Enomoto; S Hayakawa; S Itsukushima; D Y Ren; M Matsuo; K Tamada; C Oneyama; M Okada; T Takumi; M Nishita; Y Minami
Journal:  Oncogene       Date:  2009-06-29       Impact factor: 9.867

Review 6.  Minireview: the OPG/RANKL/RANK system.

Authors:  S Khosla
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

7.  The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells.

Authors:  Julia Billiard; Deana S Way; Laura M Seestaller-Wehr; Robert A Moran; Annamarie Mangine; Peter V N Bodine
Journal:  Mol Endocrinol       Date:  2004-09-23

Review 8.  Control of RANKL gene expression.

Authors:  Charles A O'Brien
Journal:  Bone       Date:  2009-08-27       Impact factor: 4.398

Review 9.  New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?

Authors:  Steeve Kwan Tat; Jean-Pierre Pelletier; Carmen Ruiz Velasco; Marc Padrines; Johanne Martel-Pelletier
Journal:  Keio J Med       Date:  2009-03

Review 10.  Role of the Wnt signaling pathway in bone and tooth.

Authors:  Masato Tamura; Eiji Nemoto; Mari M Sato; Aiko Nakashima; Hidetoshi Shimauchi
Journal:  Front Biosci (Elite Ed)       Date:  2010-06-01
View more
  1 in total

1.  Skeletal growth and the changing genetic landscape during childhood and adulthood.

Authors:  Dana L Duren; Maja Seselj; Andrew W Froehle; Ramzi W Nahhas; Richard J Sherwood
Journal:  Am J Phys Anthropol       Date:  2013-01       Impact factor: 2.868

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.